Cesca Therapeutics (KOOL) closed the most recent trading day at $0.38, moving -0.73% from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.44%. Elsewhere, the Dow lost 1.27%, while the tech-heavy Nasdaq lost 2.06%.
Prior to today's trading, shares of the company had lost 3.55% over the past month. This has lagged the Medical sector's loss of 2.15% and the S&P 500's loss of 2.61% in that time.
Wall Street will be looking for positivity from KOOL as it approaches its next earnings report date. This is expected to be November 13, 2018. On that day, KOOL is projected to report earnings of -$0.10 per share, which would represent year-over-year growth of 58.33%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.97 million, down 3.26% from the year-ago period.
Investors might also notice recent changes to analyst estimates for KOOL. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. KOOL currently has a Zacks Rank of #3 (Hold).
Digging into valuation, KOOL currently has a Forward P/E ratio of 3.83. This valuation marks a discount compared to its industry's average Forward P/E of 33.56.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 83, which puts it in the top 33% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cesca Therapeutics Inc. (KOOL) : Free Stock Analysis Report
To read this article on Zacks.com click here.